Chemotherapy and Radiation
691 articles
If Something Feels Wrong, Insist on Testing
Kristin Sine wanted an answer to her mysterious pain, but she had to insist on testing to find out she had a pancreatic neuroendocrine tumor.
Molecular Profiling: Getting to Know Your Tumor
Dr. Johanna Bendell explains the value of molecular profiling, which can indicate the best type of chemotherapy for your tumor.
The Importance of Clinical Trials
Judith Goldring outlines her treatments for pancreatic cancer using a series of clinical trials, as her cancer progresses.
Combining Gene Therapy with Current First-line Treatments for Metastatic Pancreatic Cancer
Gene therapy combined with standard first-line chemotherapy treatment forms a clinical trial for metastatic pancreatic cancer.
Very Fortunate to Have the Whipple
Six years after surgery to remove an IPMN neoplasm, Rosemary Buden found out she had pancreatic cancer and needed a Whipple procedure.
Testing Standard Treatment Plus an Antibody to Shrink Pancreatic Tumors
Researchers are testing whether adding a monoclonal antibody to standard chemotherapy will make locally advanced pancreatic cancer qualify for surgery.
Trying a New Type of Treatment to Stop Advanced Pancreatic Cancer
Researchers test the chemotherapy combination of AM0010 and FOLFOX as a second-line therapy for people with metastatic pancreatic cancer.
Predicting Effective Therapy in Pancreatic Cancer
Dr. Kenneth Yu is leading a clinical trial that looks at a pancreatic cancer patient’s pharmacogenomic profile, to see which chemotherapy works better.
mRNA Pancreatic Cancer Vaccine Trial Heading for Phase II
Dr. Vinod Balachandran provides the latest data on the mRNA pancreatic cancer vaccine, now headed to a phase II clinical trial.
A New Triple Combination for Tumors with BRCA1/2 or PALB2 Mutations
A clinical trial is comparing a two-drug combination with a three-drug combination to see which works better for genetic mutations.
Testing a Virus to Help Kill Pancreatic Tumor Cells
Researchers are testing whether cold virus can penetrate the tumor stroma and help kill pancreatic cancer cells.
Testing a PARP Inhibitor for Metastatic Pancreatic Cancer Patients with DNA Repair Mutations
Researchers are testing a PARP inhibitor that is effective for cancers in pancreatic cancer patients with DNA repair mutations.
Should Cancer Patients Get the COVID-19 Vaccine? Yes!
Should pancreatic cancer patients get the COVID-19 vaccine? According to the experts, yes, and as soon as they can.
New and Wonderful Things
Long-term survivor Camille Moses updates Let’s Win on her activities as an advocate for research funding and patients in treatment.
Leave No Stone Unturned
Long-term survivor Julie Lopp was diagnosed with pancreatic cancer, she told her friends that all she wanted was more of every single day.